JPRN-UMIN000015226招募中未知
A phase 2 study of cisplatin plus pemetrexed followed by maintenance pemetrexed in unresectable malignant pleural mesothelioma - Cisplatin plus pemetrexed followed by maintenance pemetrexed in unresectable malignant pleural mesothelioma
Kyoto Thoracic Oncology Research Group0 个研究点目标入组 45 人开始时间: 2014年9月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) With interstitial pneumonitis or pulmonary fibrosis which chest X-P can detect 2) With fluid accumulation which shoud be treated 3) With active double cancer 4) Patients who had already undergone cisplatin or pemetrexed 5) With poor-controled diabetes mellitus or hypertension 6) With liver cirrhosis diagnosed by imaging findings or clinical findings 7) History of severe heart disease (acute cardiac infarction or unstable angina within 6 months of registration, post-PTCA, post-CABG, sign of heart failure, uncontrollable arrythmia) 8) History of active infection 9) History of pregnancy or lactation 10) Sever drug allergy 11) No consent to blood transfusion 12) Evidence of bleeding tendency 13) No premedication of pemetrexed 14) Those judged to be not suitable by the attending physician
研究者
相似试验
已完成
2 期
A phase 2 study of cisplatin/pemetrexed followed by maintenance pemetrexed in patients with stage 3B or 4 non-squamous non-small-cell lung cancer.Previously untreated stageIIIB/IV non-squamous non-small-cell lung cancerJPRN-UMIN000002686Kinki-chuo chest medical center35
进行中（未招募）
不适用
Phase I/II study with cisplatin and pemetrexed +/- sorafenib in malignant pleural mesothelioma (SoMe study) - SoMe Studymalignant pleural mesothelioma (MPM)MedDRA version: 9.1Level: LLTClassification code 10059518Term: Pleural mesothelioma malignantEUCTR2007-005894-77-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
已完成
2 期
Phase II study of cisplatin, pemetrexed plus bevacizumab for EGFR mutation negative or unknown stage III/IV non-small-cell lung cancer (non-squamous cell lung cancer)EGFR mutation negative or unknown stage III/IV non-small-cell lung cancer (non-squamous cell carcinoma)JPRN-UMIN000003855Departmnent of Thoracic Oncology Kanagawa Cancer Center25
进行中（未招募）
1 期
Phase I/II Study of Concurrent Cisplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung Cancer - N/AEUCTR2006-003007-39-NLEli Lilly and Company limited60
进行中（未招募）
不适用
Phase I/II Study of Concurrent Cisplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung Cancer - N/Aimited Stage Small Cell Lung CancerMedDRA version: 8.1Level: LLTClassification code 10041069Term: Small cell lung cancer limited stageEUCTR2006-003007-39-BEEli Lilly and Company limited61